Haiyan Xu
Third Affi liated Hospital of Soochow University, China
Biography
Haiyan Xu has devoted herself on relative study of kidney transplantation, including rejection, opportunistic viral infection and induction of immune tolerance, since she got PHD. Taking B cell activating factor (BAFF) as the research breakthrough point, she found BAFF signaling system involve in the progression of renal allograft rejection and blockade of BAFF signaling should become the potential anti-rejection options; BAFF signaling crosstalk with HCMV/TLR9 in renal transplant recipients, which would decrease the long-term outcome of renal allograft, and mouse DC induced by liver X receptor agonist show immunosuppressive effect, which differ from natural tolerance DC.